| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Research Laboratory and Department of Bacteriology and Immunology, University of California, Berkeley, California 94720
Eight mammary carcinomas were induced by either 3-methylcholanthrene or 7,12-dimethylbenz(a)anthracene in a nonviral- and noncarcinogen-induced preneoplastic (premalignant) alveolar nodule which had arisen in a hormonally stimulated BALB/c female mouse. The preneoplastic mammary nodule outgrowth was found to be nonantigenic when tested in the strain of origin. Seven of the eight carcinogen-induced carcinomas were also found to exhibit no clear-cut evidence of antigenicity. The eighth tumor, however, was shown to produce tumor-specific immunity in BALB/c mice.
The results suggest that carcinogens may not directly induce the appearance of new antigens in the tumors they produce. Furthermore, carcinogens may act in a different manner when inducing a preneoplastic change than when inducing a tumor from a preexisting preneoplastic lesion.
1 This work was supported by NIH Grants CA-5388 and CA-5045, by Grant PRA-37 from the American Cancer Society, and by cancer research funds of the University of California, Berkeley, Calif. 94720.
2 Present address: Department of Radiation Medicine, Massachusetts General Hospital, Boston, Mass. 02114.
Received 3/10/72. Accepted 6/23/72.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |